KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Non-Current Debt (2018 - 2025)

Historic Non-Current Debt for ClearPoint Neuro (CLPT) over the last 12 years, with Q3 2025 value amounting to $29.2 million.

  • ClearPoint Neuro's Non-Current Debt changed N/A to $29.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.2 million, marking a year-over-year change of. This contributed to the annual value of $9.9 million for FY2023, which is 56.61% up from last year.
  • As of Q3 2025, ClearPoint Neuro's Non-Current Debt stood at $29.2 million.
  • ClearPoint Neuro's Non-Current Debt's 5-year high stood at $29.2 million during Q3 2025, with a 5-year trough of $9.8 million in Q4 2021.
  • Its 4-year average for Non-Current Debt is $14.5 million, with a median of $9.9 million in 2023.
  • Its Non-Current Debt has fluctuated over the past 5 years, first skyrocketed by 282062.88% in 2021, then crashed by 5981.64% in 2022.
  • ClearPoint Neuro's Non-Current Debt (Quarter) stood at $9.8 million in 2021, then grew by 0.56% to $9.9 million in 2022, then grew by 0.57% to $9.9 million in 2023, then surged by 193.53% to $29.2 million in 2025.
  • Its Non-Current Debt was $29.2 million in Q3 2025, compared to $28.8 million in Q2 2025 and $9.9 million in Q4 2023.